Protagonist Therapeutics (PTGX) total debt

Total debt · fiscal 2025
$10.32M

Protagonist Therapeutics (PTGX) carried total debt of $10.32M at the end of fiscal 2025 (December 31, 2025). That is 5.0% lower than the $10.87M of fiscal 2024. Figures as of 18 Nov 2026, 09:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$10.32M
Change on fiscal 2024
−5.0%
Highest on record
$10.87Mfiscal 2024
Lowest on record
$1.14Mfiscal 2023
Fiscal years on record
52019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Protagonist Therapeutics total debt, in more detail

Across the 5 fiscal years on record (2019–2025), the highest was $10.87M in fiscal 2024 and the lowest $1.14M in fiscal 2023.

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

History · 5 fiscal years

Total debt by fiscal year

Protagonist Therapeutics total debt, year by year

Protagonist Therapeutics (PTGX) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$10.32M 5.0% down0.0×
2024$10.87M 852.3% up0.0×
2023$1.14M 68.8% down0.0×
2022$3.66M—0.0×
2019$9.79M—0.1×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Protagonist Therapeutics and comparable companies
CompanyTotal debtFiscal year
Praxis Precision Medicines PRAX$110.00K2025
Twist Bioscience TWST$94.99M2026
Protagonist Therapeutics PTGX$10.32M2025
Krystal Biotech KRYS$9.34M2025
10x Genomics TXG$84.36M2025
HealthEquity HQY$1.00B2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PTGX

Protagonist Therapeutics, figure by figure

Protagonist Therapeutics (PTGX) overview: price, valuation and scorecardAll health care companies by market value

Protagonist Therapeutics total debt: questions and answers

How much debt does Protagonist Therapeutics have?

Protagonist Therapeutics (PTGX) carried total debt of $10.32M at the end of fiscal 2025 (December 31, 2025). That is 5.0% lower than the $10.87M of fiscal 2024.

What are the highest and lowest total debt figures on record for Protagonist Therapeutics?

Across the 5 fiscal years on record (2019–2025), the highest was $10.87M in fiscal 2024 and the lowest $1.14M in fiscal 2023.

How does Protagonist Therapeutics's debt compare with its equity?

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

How is Protagonist Therapeutics's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Protagonist Therapeutics it is on record here for 5 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Protagonist Therapeutics (PTGX) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/PTGX/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.